Plasma fractionation presents demanding cleaning challenges. Process streams contain complex proteinaceous soils, equipment may operate in campaigns or support multiple products, and cleaning cycles must consistently meet established residue and microbial acceptance criteria.

CIP performance therefore depends on more than cleaning chemistry, temperature, time, and bulk flow rate. The geometry of the equipment being cleaned, including every valve, is part of the validated system.

Two Different Retention Mechanisms

Dead-leg discussions commonly focus on branch length and drainability. Those factors are important, but they do not capture every location in which residue may be retained.

Geometric dead legs and poorly swept branches

A geometric dead leg is created when an installed branch or process connection extends away from the primary flow path and is not effectively swept during cleaning.

The relevant questions include:

• How far is the valve sealing point from the primary flow path?
• Is the branch self-draining in its installed orientation?
• Does cleaning solution exchange effectively throughout the branch?
• Are adequate wall shear and chemical exposure achieved at the most difficult-to-clean surface?

A conventional weir-style diaphragm valve is not automatically a dead leg. Its cleanability depends on the valve configuration, branch geometry, orientation, diaphragm position, and the way it is incorporated into the system.

Peripheral body-seal retention

A second concern can occur at the interface where a conventional diaphragm is compressed between the valve body and bonnet or actuator assembly. Depending on the design, diaphragm material, assembly conditions, thermal cycling, and service history, this peripheral sealing region may create a narrow retention area that is difficult to inspect and challenging to clean reproducibly.

We sometimes describe this as an asymptotic dead leg: a location where cleaning can continue to improve with additional time, chemistry, or flow, but where the geometry itself limits direct access to the retained soil.

This is an explanatory engineering term, not a formal ASME BPE definition. Its value is that it directs attention beyond conventional branch-length measurements to the actual product-contact sealing interface.

Why These Details Matter in Plasma Fractionation

Plasma-derived manufacturing combines variable biological feedstocks with protein- and lipid-containing soils that can be difficult to remove. Many facilities also operate through extended campaigns or use common equipment for multiple fractions or products.

These conditions increase the importance of:

• repeatable soil removal
• effective equipment drainability
• representative rinse or direct-surface sampling
• scientifically justified residue limits
• control of accumulation over repeated cycles
• prevention of product carryover and cross-contamination

A valve can meet dimensional and material requirements yet still contain a location that is comparatively difficult to clean. That difference may not become evident until cleaning-cycle development, qualification, or continued process verification.

How Radial Diaphragm Geometry Changes the Cleaning Boundary

The Rattiinox CAD valve uses a radial diaphragm architecture rather than the conventional weir configuration.

Its process path is designed around a short distance between the process connection and the central sealing area. Product and cleaning solution move through a compact, drainable chamber that is swept toward the valve seat. The diaphragm-to-body seal is positioned so that the conventional peripheral body-seal entrapment mechanism is avoided within the product-contact chamber.

The distinction is not merely that the flow changes direction. It is that the valve body, sealing point, diaphragm, and process connection are designed together to reduce hold-up and remove difficult-to-clean peripheral sealing geometry.

For CIP system design, this can provide:

• fewer poorly swept internal surfaces
• reduced residual hold-up
• improved drainability
• more direct exposure of product-contact surfaces to cleaning solution
• a stronger engineering basis for cleaning-cycle development and validation

Actual performance must still be confirmed for the process soil, operating conditions, cleaning parameters, sampling method, and acceptance criteria established by the manufacturer.

Cleanability Must Be Designed Into the System

ASME BPE places considerable emphasis on hygienic design, cleanability, drainability, and the control of dead legs. These principles should be applied to the complete installed system rather than evaluated only from a component datasheet.

That means reviewing valve selection at the P&ID and equipment-design stages, when the project team can still evaluate:

• the location of every valve sealing point
• branch dimensions and orientation
• drainability in the installed position
• valve-body and diaphragm sealing geometry
• access for inspection or sampling
• anticipated process soils
• CIP flow paths and operating sequences

This approach is consistent with the broader Clean by Design principle now being developed through ASTM E55.11: cleaning requirements should influence equipment design before the cleaning process must be validated around fixed hardware. See the ASTM E55.11 Clean by Design work item.

What This Means for New Fractionation Capacity

For new or expanded plasma fractionation facilities, valve geometry should be reviewed during basic and detailed design, not after the CIP system has been commissioned.

This applies to:

• plasma pooling and transfer
• precipitation and separation
• chromatography and buffer distribution
• intermediate hold vessels
• WFI distribution
• CIP supply and return systems
• product-recovery and transfer panels

A difficult-to-clean valve location may be exposed to thousands of production, CIP, and SIP cycles over the facility lifecycle. Addressing that geometry during design is generally less disruptive than compensating for it later through extended cleaning cycles, additional sampling, maintenance intervention, or equipment modification.

Working With PharmAseptic

PharmAseptic supplies Rattiinox CAD radial diaphragm valves throughout North and South America, as well as NovAseptic radial diaphragm valves for appropriate hold-vessel and transfer applications.

If you are specifying valve packages for a new plasma fractionation facility, or investigating recurring cleaning-validation variability in an existing system, we can review the actual flow paths and valve locations on your P&ID.

Contact PharmAseptic to discuss your applicationsWFI recirculation cluster.